Revvity, Inc. (RVTY) is a Medical - Diagnostics & Research company in the Healthcare sector, listed on NYSE. At USD 151.65 it trades at 80% of its 52-week range (USD 81.22 – 169.06).
Otharis Plus · ProAnalysed Nov 02, 2026 from its filings
Is Revvity worth more than its price — and is its growth accelerating?
Two complete methods, run on RVTY's own numbers: Benjamin Graham's value test and the Otharis Growth Score. Every number is real and computed — never estimated.
Value Investing · Benjamin Graham7 criteria · value vs price · margin of safety
The verdict, the values and every number behind them are inside Otharis.
✨
Otharis Research Free
A real, deterministic 22-section research report for RVTY - every line tagged FACT, MODEL OUTPUT, ASSUMPTION, ESTIMATE or RULE-BASED INTERPRETATION. 2 reports a day with a free account.